Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LT-α and MMP-9 as biomarkers and treatment predictors in contact lens-related dry eye
ChiCTR2600127662Phase 4Not yet recruiting
- Sponsor
- Tianjin Medical University Eye Hospital
- Start
- Jul 2026
- Modality
- Recombinant Proteins and Enzymes, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial in dry eye syndrome (DED) comparing Control group (0.1% sodium hyaluronate) with Experimental group (Cationorm) (2 arms). Primary endpoints: tear MMP-9 concentration, tear LT-α concentration and 1 more. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
cationormsodium hyaluronate
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on ChiCTR2600127662.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600127662.